| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.05 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |